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The toxicity of okadaic acid (OA) and yessotoxins (YTXs) was
studied in mice orally fed on (i) OA (17.80±2.41 µg/Kg) for
24 h and mouse feed for 24 h; (ii) OA (17.2±2.13 µg/Kg)
plus YTXs (1.30±0.12 mg/Kg) for 24 h and mouse feed for
24 h; (iii) OA (18.88±1.86 Ìg/Kg) plus YTXs (1.45±0.12
mg/Kg) for 24 h. After toxin treatments the thymus and
spleen were examined. More severe morpho-functional mod-
ifications were found in the thymus, which presented atrophy,
a significant depletion in the lymphoid compartment and
angiogenesis. In spite of the impairment, a number of
inflammatory cells, reactive to anti-cytokine antibodies, were
recruited. Moreover, greater expression of matrix metallopro-
teinase-9, particularly in cells located near new blood ves-
sels, was observed. Thymus injury was still observed after 48
h. Histopathological changes to the spleen were more evi-
dent in mice orally treated for 24 h and immediately sacri-
ficed. The organ showed a significant loss of volume and a
fibrous component invaded regions involved in immune func-
tions. In white pulp the marginal zones were reduced, lym-
phoid nodules contained large germinal centres and the
periarteriolar lymphoid sheaths showed cellular depletion.
An inflammatory cell response was activated by the recruit-
ment of granulocytes, an increased number of active
macrophages and increased immunoreactivity to cytokines.
Unlike in the thymus, some evidence of recovery was seen in
the spleen. The data suggest that low oral doses of OA alone
or OA plus YTXs are able to provoke immunostimulation and
systemic immunotoxicity, thus also indicative of tumorigenic
properties.
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T
he defence system is one of the targets of
marine algal toxins. Ito and colleagues
(1997) reported that repeated injection in
male ICR mice of low doses of the toxin palytoxin
provoked damage to the lymphoid tissues.
Furthermore, oral administration in male ICR mice
of azaspiracid provoked serious pathological
changes to the thymus, spleen and Peyer’s patches,
and both T and B lymphocytes were injured (Ito et
al., 2000, 2002a). Recently, we have found that the
intra-peritoneal (i.p.) injection of lethal and sub-
lethal doses of yessotoxin (YTX) in male Swiss CD1
mice acts primarily on the immune system
(Franchini et al., 2004a). The structural organisa-
tion of the thymus microenvironment appeared par-
ticularly offended. The epithelial compartment
showed modifications in morphology and cytoker-
atin expression, while the number of apoptotic thy-
mocytes increased significantly. Subsequently, a
reduced thymocyte population left the organ to
colonise T cell areas of peripheral lymphoid organs
resulting in an impaired, cell-mediated immune
response. The thymus cytokine response was also
modified by i.p. YTX. Careful attention is required
in assessing the immunotoxic potential of algal tox-
ins, and account must be taken of the well-estab-
lished correlation between the suppression of
immune functions and the increased incidence
and/or severity of neoplastic diseases (Germolec,
2004).
Studies from different laboratories of another
algal toxin, okadaic acid (OA), have indicated the
small intestine as the target organ (Edebo et al.,
1988; Ito and Terao, 1994; Ito et al., 2002b). The
capacity of OA to promote tumour formation has
been reported (Suganuma et al., 1988). The mode
of action of this toxin has been indicated as the inhi-
bition of protein phosphatase 1 and 2A (Bialojan
and Takai, 1988; Suganuma et al., 1992). On the
other hand, a clearer pattern of YTX action has only
emerged recently. In vitro studies have demonstrat-
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ed the ability to destroy the E-cadherin-catenin sys-
tem selectively (Ronzitti et al., 2004). In addition
to the thymus,YTX acts in mice at different levels,
i.e. intestine and brain, with time and dose-depend-
ent effects (Franchini et al., 2004 a, b). In particu-
lar the brain, is sensitive only to a lethal i.p. YTX
dose (Franchini et al., 2004 b).
The present study reports the results obtained in
male Swiss CD1 mice fed on OA and YTXs con-
taminated mussel digestive gland. In particular, we
have focused our attention on the effects of OA
alone and OA plus YTXs on the lymphoid tissue of
the thymus and spleen.
Materials and Methods
Animals and toxin treatment
Male Swiss CD1 mice weighing 20-21 g obtained
from Morini (San Polo d’Enza, RE, Italy) were
used. The animals were maintained in conformity
with guidelines in the European Communities
Council Directive (86/609 ECC) concerning animal
welfare and fed with standard diet for rodents (M
mucedola, srl, MI, Italy).Three groups of 5 animals
were orally administered toxin as follows: group A
was fed on OA (17.80±2.41 µg/Kg) contaminated
boiled mussel digestive gland for 24 h, followed by
mouse feed for 24 h; group B was fed on OA
(17.2±2.13 µg/Kg) plus YTXs (1.30±0.12 mg/Kg)
contaminated boiled mussel digestive gland for 24
h, followed by mouse feed for 24 h; group C was fed
on OA (18.88±1.86 µg/Kg) plus YTXs (1.45±0.11
mg/Kg) contaminated boiled mussel digestive gland
for 24 h. The toxin concentrations were evaluated
by HPLC after mussel boiling. After toxin treat-
ments, the animals were sacrificed and the thymus
and spleen dissected for the histological, histo-
chemical and immunocytochemical examination. A
further five animals were used as controls.
Evaluation of toxins by HPLC method
The presence of OA and YTXs in the mussel diges-
tive glands fed to the mice was evaluated using the
HPLC method with fluorescent detector following
the procedure of Lee et al. (1987) and Yasumoto
and Takizawa (1997), respectively.
Histological and histochemical procedures
Thymus and spleen from treated and animals and
controls were fixed in 10% neutral formol and
Bouin's mixture, embedded in paraffin wax and cut
into 7 µm sections. The following stains were per-
formed (Bancroft and Stevens, 1996): hema-
toxylin/eosin and trichrome stainings for general
morphology; PAS/hematoxylin for carbohydrates,
and silver impregnation method for reticular fibres.
Immunocytochemical procedure
For the immunocytochemical procedure, the sec-
tions were incubated overnight at 4°C with the fol-
lowing primary antibodies: anti-cytokeratin 1
(CK1) monoclonal antibody (mAb) (1:1000)
(Novocastra Laboratories, Newcastle, UK); anti-
cytokeratin 8 (CK8) mAb (1:1000) (Novocastra);
anti-cytokeratin 18 (CK18) mAb (5 mg/mL)
(Roche Molecular Bichemicals, Germany); anti-
cytokeratin 1/5/10/14 (CK1/5/10/14) mAb
(1:1000) (Novocastra); matrix metalloproteinase
(MMP)-9 mAb (1:1000) (Novocastra); anti-IL-1·
polyclonal antibody (pAb) (1:500) (R & D
Systems, Minneapolis, MN, USA); and anti-IL-6
pAb (1:500) (R & D Systems). The labelling sites
were revealed using avidin-biotin-peroxidase com-
plex (ABC). Nuclei were counterstained with hema-
toxylin. Negative controls were performed by sub-
stituting the primary antibodies with non-immune
sera. A detailed immunocytochemical protocol is
described elsewhere (Ottaviani et al., 1995).
Quantification of thymus and spleen areas
Organ sizes were evaluated by determining the
areas of the thymus and spleen sections using the
Scion Image for Windows software (Scion corpora-
tion, Maryland, USA).The differences between con-
trol and treated samples were analysed statistical-
ly by ANOVA.
Results
The oral toxicity of OA alone and OA plus YTXs
affected both the thymus and spleen, but more
severe structural and functional damage was found
in the thymus.The organ was considerably reduced
in size, decreasing more than four-fold (Figure 1).
The most altered thymus area appeared to be the
cortex and, in particular, the outer region, where a
severe depletion of lymphoid cells, an increase in
the non-lymphoid compartment and a fibrous invo-
lution were observed (Figure 2a, d). Rare struc-
turally intact lympho-epithelial areas were also
seen, as well as extensive angiogenesis, with the for-
mation of new blood vessels (Figure 2d). The
medulla was hardly distinguishable and reduced to
small islets, in which small groups of densely
packed thymocytes and some apoptotic phenotypes
were seen to surround the blood vessels (Figure 2e,
f). The development of heterogeneous, Hassall’s
corpuscle-like bodies was also evident.The immuno-
cytochemical reactions demonstrated changes in
the expression of cytokeratin intermediate filament
protein in the epithelial thymus sub-populations. In
comparison with controls, the thymus from treated
animals showed a more extensive network of both
low MW cytokeratin (CK8, CK18) and high MW
cytokeratin (CK1, CK1/5/10/14) reactive epithelial
cells in the cortex (Figure 3a, b). In medullary
areas, the epithelial cells were sometimes struc-
turally modified into round cells and showed
stronger immunoreactivity to high MW cytoker-
atins (Figure 3c and d).The cytokine response, i.e.
IL-1α and IL-6, revealed a higher number of posi-
tive cells, which were mainly inflammatory cells,
such as granulocytes and macrophages (Figure 3e,
f). In control thymus, rare isolated cells in the cor-
tex and a higher number in the cortico-medullary
junction and medulla were stained with anti-MMP-
9 mAb (Figure 4a, b). After oral toxin administra-
tion, the number of immunoreactive cells and the
reaction intensity increased. Most of these cells
showed the morphological characteristics of
macrophages. Strongly positive cells were seen in
the outer cortex and near the new blood vessels
which had reactive, flattened endothelial cells
(Figure 4c, d). Moreover, the intercellular spaces of
this thymus area were immunoreactive (Figure 4e).
There were no significant differences in findings
under the three experimental conditions (Figure
4c,f). The structural organization of the spleen of
orally toxin-treated animals showed particularly
evident modifications in group C.The organ showed
a significant loss of volume (Figure 5). In the white
pulp, the marginal zone, clearly seen in controls,
was reduced, contained more fibroblasts and was
partly replaced by thick trabeculae invading the
spleen parenchyma from the external capsule
(Figure 6a, b).The spleen lymphoid nodules showed
large germinal centres containing clusters of large
lymphocytes and groups of dead cells.The periarte-
riolar lymphoid sheaths (PALS), enriched in bun-
dles of reticular fibres, surrounded enlarged arteri-
oles and showed cellular depletion (Figure 6d and
e).The fibrous trabeculae also invaded the red pulp
to the detriment of the cellular component.
Immunocytochemical reactions with anti-cytokine
pAbs demonstrated groups of intensely stained cells
localised in the PALS (Figure 6i) and red pulp
spleen cords (Figure 7b).These were mainly inflam-
matory cells, such as granulocytes and
macrophages in active phase (Figure 7c). In control
spleen, a few, isolated immunoreactive cells were
seen (Figure 6h and 7a). In spleen from group A
and group B samples, more limited structural alter-
ations, e.g. an increase in the fibrous component
(Figure 6g) and a reduction in marginal zones, were
evident than group C animals. The development of
germinal centres was stimulated (Figure 6c) and
cytokine response was similar to group C. A signif-
icant loss of volume was not observed (Figure 5).
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Figure 1. Thymic section areas from control  and toxin orally
administered mice. Statistical significance is determined by
ANOVA ( p<0.05 vs control). 
Figure 5. Spleen section areas from control  and toxin orally
administered mice. Statistical significance is determined by
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Figure 2. Thymic sections from control (a, c), orally administrated group A (d-f) and group B (b) mice. Trichrome (a, b), silver impreg-
nation (c, d) and  hematoxylin/eosin stains (e, f). A severe depletion in thymocyte population (b) and angiogenesis (d) are found in
cortical areas after oral treatments. Note densely packed thymocytes surrounding blood vessel in a medullary area (e, f). Cortex (C);
blood vessels (arrows), apoptotic cells (arrowheads). Bars = 20 µm.
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Figure 3. Thymic sections  from control (a, c, e), orally administrated group A (b, d) and group B (f) mice, immunostained with anti-CK
1 mAb (a, b); anti-CK 1/5/10/14 mAb (c, d) and anti-IL-1α pAb (e, f). Cortex (C); medulla (M), granulocytes (arrows). Bars = 20 µm.
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Figure 4. Thymic sections  from control (a, b), orally administrated group A (c, d), group B (e) and group C (f)  mice immunostained
with anti-MMP-9 mAb. In controls, positive cells (arrows) are rare in cortex and more abundant in cortico-medullary junction and
medulla. In treated samples, the number of immunoreactive cells and reaction intensity increase. Reactive endothelial cells (arrow-
heads), cortex (C); medulla (M). Bars = 20 µm.
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Figure 6. Spleen sections from control ( a, d, f, h), orally administrated group A (c), group B (g) and group C (b, e, i) mice. PAS/hema-
toxylin (a, b, f, g), silver impregnation (d, e) and hematoxylin/eosin stains (c). In treated samples white pulp marginal zone (MG) is
reduced (b) and developed germinal centres contain many dead cells (arrows) (c). The periarteriolar lymphoid sheaths (PALS) sur-
round enlarged arterioles and are invaded by reticular fibres (e). Note trabecular invasion of red pulp (g). White pulp PALS  immunos-
tained with anti-IL-1· pAb (h, i). Bars = 20 µm.
Discussion
We have observed a severe alteration in the struc-
tural architecture of the thymus following oral
administration of OA and OA plus YTXs.The organ
exhibits strong atrophy, with significant histological
modifications in the outer cortex and medulla,
where there is conspicuous depletion of thymus
lymphoid elements. Most of the outer cortical
region shows disorganization of the lympho-epithe-
lial complexes, an increase in epithelial cytokeratin
expression and an invasion of fibrous components
and angiogenetic areas.
Physiological thymocyte migration and differenti-
ation are considered the result of multiple cellular
interactions between microenvironment compo-
nents and simultaneous and/or sequential stimuli
involving chemokines and extracellular matrix pro-
teins controlling matrix production and degrada-
tion (Savino et al., 2003). In this context, key mol-
ecules are matrix metalloproteinases (MMPs),
good candidates for the intrathymic, extracellular
matrix breakdown facilitating T cell migration
(Goetzl et al., 1996). Recently, some MMPs have
been shown to be constitutively expressed in the
human thymus (Kondo et al., 2001) and utilized to
disrupt the tissue matrix by mature T cells (Leppert
et al., 1995; Xia et al., 1996). On the other hand,
MMPs and, in particular, MMP-9 modulate neo-
vascularization, which is known to be necessary for
tumour growth and metastasis, by mediating the
release of vascular endothelial growth factor from
extracellular stores and the angiogenic switch
(Bergers et al., 2000).The increased expression of
MMP-9 at protein or mRNA level has been corre-
lated to thymus epithelial tumour (Yukiue et al.,
2003; Sogawa et al., 2003; Takahashi et al.,
2003). Here we demonstrate greater expression of
MMP-9, especially in cells located near angio-
genetic areas, and modifications in epithelial phe-
notypes after algal toxin treatment.These observa-
tions may support tumorigenic properties.
Suganuma et al., (1988) also demonstrated a
tumour promoting activity for OA, and our experi-
mental conditions, we have not seen any significant
different damages to the thymus of mice fed on OA
alone or OA plus YTXs. A dose- and time-depend-
ent immunotoxicity of algal toxins may be surmised
as indicated  for i.p. injected YTX (Franchini et al.,
2004a). Low oral doses of OA provoke more severe
thymocyte depletion than higher doses of YTX
administered by i.p. injection (Franchini et al.,
2004a).Tubaro et al. (2004) found that continuous
oral exposure to YTX provoked less toxic effects
than the same or lower exposure to OA. On the
other hand, a sub-lethal i.p. YTX dose was able to
provoke more severe damage to mice thymus after
24 h than a lethal dose (death within 2 h) which
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Figure 7. Sections of spleen  from control (a) and orally administrated group C (b, c) mice. Red pulp cords immunostained with anti-
IL-1α pAb. Note an active macrophage with a cytoplasmic phagocytic vacuola (arrow). Bars = 20 µm
resulted in a reduced thymocyte population
(Franchini et al., 2004a).This observation may sup-
port a similar systemic immunotoxicity of OA and
YTXs, but with differing degrees of toxicity over
time.
The target organ of OA has been considered the
small intestine, and the changes provoked by sub-
lethal, oral doses were observed after 1 h with near-
ly complete recovery within 48 h (Ito and Terao,
1994; Ito et al., 2002b).The present findings point
out the high sensitivity of the thymus to oral toxin
treatments, as the organ was still severely injured
after 48 h and functionality had not been restored.
With regard to the spleen, histopathological
changes were more evident in mice orally treated
for 24 h and immediately sacrificed. The thymus
atrophy and the consequent reduction in the num-
ber of T cells leaving the organ led to a reduction in
the number of cells observed in PALS, so altering
spleen white pulp function. The spleen size showed
significant loss of volume and a fibrous component
invaded regions involved in immune functions, i.e.
the marginal zones. Mouse spleen architecture is
that of a defensive spleen (Haley, 2003) with abun-
dant lymphoid tissue providing immunological
defence cells. After oral algal toxin administration,
an inflammatory cell response is activated by the
recruitment of granulocytes, an increase in the
number of active macrophages and immunoreactiv-
ity to cytokines. Moreover, the development of the
large germinal centres was stimulated, indicating
activation of spleen function in response to sys-
temic immunotoxicity. Unlike in the thymus, there
was some evidence of recovery in the spleen. Ito et
al. (2002b) investigated the distribution and excre-
tion of orally administered OA in mice and observed
that some toxin becomes inactive, but is still pres-
ent, after two weeks. Atrophic signs in the spleen
and thymus have also been observed after oral
administration of high doses of OA (Tubaro et al.,
2004) or other algal toxins such as azaspiracid (Ito
et al., 2000; 2002a).
In general, the data presented here suggest that
low doses of OA alone or OA plus YTXs are able to
provoke both immunostimulation and systemic
immunotoxicity.
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